BerGenBio AS has appointed Heidi Pavliska as a director. She previously was an associate director for business development at Galapagos NV.
BerGenBio is a preclinical-stage Norwegian biotech company which is investigating inhibitors that block the mechanisms by which tumour cells metastasise and become drug resistant.
Copyright 2011 Evernow Publishing Ltd